Cyclophosphamide/docetaxel/doxorubicinBenign melanonychia striata: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1492卷 / 1期

关键词：

D O I：

10.1007/s40278-014-9373-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[21] Cyclophosphamide/docetaxel/doxorubicinVarious toxicities: case report
Reactions Weekly, 2018, 1727 (1) : 100 - 100
[22] Cyclophosphamide/docetaxel/doxorubicinExtramedullary haematopoiesis: case report
Reactions Weekly, 2009, 1253 (1) : 13 - 13
[23] Cyclophosphamide/docetaxel/epirubicinHeart attack: case report
Reactions Weekly, 2024, 2023 (1) : 124 - 124
[24] Cyclophosphamide/docetaxel/doxorubicinNeutropenic enterocolitis: case report
Reactions Weekly, 2020, 1812 (1) : 88 - 88
[25] Ciclosporin/mycophenolate-mofetilPigmented squamous cell carcinoma and melanonychia striata: case report
Reactions Weekly, 2015, 1557 (1) : 65 - 65
[26] Cyclophosphamide/docetaxel/gemcitabineErectile dysfunction: case report
Reactions Weekly, 2020, 1830 (1) : 123 - 123
[27] Cyclophosphamide/docetaxel/epirubicinGlioblastoma multiforme: case report
Reactions Weekly, 2025, 2048 (1) : 139 - 139
[28] Cyclophosphamide/docetaxel/doxorubicinAcute enterocolitis: case report
Reactions Weekly, 2009, 1251 (1) : 14 - 14
[29] Cyclophosphamide/docetaxel/epirubicinCardiac dysfunction: case report
Reactions Weekly, 2021, 1859 (1) : 116 - 116
[30] Cyclophosphamide/docetaxel/doxorubicin/trastuzumabLymphoedema (first report for cyclophosphamide and trastuzumab): case report
Reactions Weekly, 2011, 1361 (1) : 16 - 16

← 1 2 3 4 5 →